Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.655 USD | -3.09% |
|
+3.98% | -51.48% |
Jul. 01 | Biora Therapeutics, Inc. Announces Positive Clinical Trial Results for BT-600 | CI |
Jun. 07 | Biora Therapeutics Provides Information to the Shareholders | CI |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Molecular Testing Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 19-04-30 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Paul W. Shabram
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-24 |
Sharat Singh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Rhode
PRN | Corporate Officer/Principal | - | - |
Robyn Hatton
HRO | Human Resources Officer | - | 13-07-31 |
Clarke Neumann
LAW | General Counsel | 60 | 14-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 14-05-31 | |
Jeffrey Alter
CHM | Chairman | 61 | 18-12-31 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Lynne Powell
BRD | Director/Board Member | 57 | 19-01-31 |
Brian Kotzin
BRD | Director/Board Member | 74 | 19-05-31 |
Jill Howe
BRD | Director/Board Member | 48 | 21-11-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,621,267 | 35,538,352 ( 97.04 %) | 737,424 ( 2.014 %) | 97.04 % |
Company contact information
Biora Therapeutics, Inc.
4330 La Jolla Village Drive Suite 300
92122, San Diego
+833 727 2841
http://www.progenity.com![address Biora Therapeutics, Inc.(BIOR)](https://cdn.zonebourse.com/static/address/108665635.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.48% | 24.29M | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- BIOR Stock
- Company Biora Therapeutics, Inc.